BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 33946750)

  • 1. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants.
    Monasky MM; Micaglio E; Vicedomini G; Locati ET; Ciconte G; Giannelli L; Giordano F; Crisà S; Vecchi M; Borrelli V; Ghiroldi A; D'Imperio S; Di Resta C; Benedetti S; Ferrari M; Santinelli V; Anastasia L; Pappone C
    Europace; 2019 Oct; 21(10):1550-1558. PubMed ID: 31292628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Phenotype Correlation of
    Milman A; Behr ER; Gray B; Johnson DC; Andorin A; Hochstadt A; Gourraud JB; Maeda S; Takahashi Y; Jm Juang J; Kim SH; Kamakura T; Aiba T; Postema PG; Mizusawa Y; Denjoy I; Giustetto C; Conte G; Huang Z; Sarquella-Brugada G; Mazzanti A; Jespersen CH; Arbelo E; Brugada R; Calo L; Corrado D; Casado-Arroyo R; Allocca G; Takagi M; Delise P; Brugada J; Tfelt-Hansen J; Priori SG; Veltmann C; Yan GX; Brugada P; Gaita F; Leenhardt A; Wilde AAM; Kusano KF; Nam GB; Hirao K; Probst V; Belhassen B
    Circ Genom Precis Med; 2021 Oct; 14(5):e003222. PubMed ID: 34461752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Characterization of Two Novel Mutations in
    Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel
    Monasky MM; Micaglio E; Ciconte G; Borrelli V; Giannelli L; Vicedomini G; Ghiroldi A; Anastasia L; Locati ET; Benedetti S; Di Resta C; Casari G; Pappone C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
    Tan BY; Yong RY; Barajas-Martinez H; Dumaine R; Chew YX; Wasan PS; Ching CK; Ho KL; Gan LS; Morin N; Chong AP; Yap SH; Neo JL; Yap EP; Moochhala S; Chong DT; Chow W; Seow SC; Hu D; Uttamchandani M; Teo WS
    Europace; 2016 Jun; 18(6):897-904. PubMed ID: 25829473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of a novel SCN5A variant associated with long QT syndrome and sudden cardiac death.
    Neubauer J; Wang Z; Rougier JS; Abriel H; Rieubland C; Bartholdi D; Haas C; Medeiros-Domingo A
    Int J Legal Med; 2019 Nov; 133(6):1733-1742. PubMed ID: 31455979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the
    Monasky MM; Micaglio E; Giachino D; Ciconte G; Giannelli L; Locati ET; Ramondini E; Cotugno R; Vicedomini G; Borrelli V; Ghiroldi A; Anastasia L; Pappone C
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel
    Micaglio E; Monasky MM; Resta N; Bagnulo R; Ciconte G; Giannelli L; Locati ET; Vicedomini G; Borrelli V; Ghiroldi A; Anastasia L; Benedetti S; Di Resta C; Ferrari M; Pappone C
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
    Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
    Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico validation revealed the role of SCN5A mutations and their genotype-phenotype correlations in Brugada syndrome.
    Pham HM; Nguyen DP; Ta TD; Le TP; Phan PH; Trinh HA; Tran TV; Luong TLA; Nguyen HM; Bui TH; Tran TH; Ta TV; Tran VK
    Mol Genet Genomic Med; 2023 Dec; 11(12):e2263. PubMed ID: 37547970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy.
    Curcio A; Malovini A; Mazzanti A; Memmi M; Gambelli P; La Rosa F; Bloise R; Indolfi C; Bellazzi R; Napolitano C
    Heart Rhythm; 2021 Oct; 18(10):1698-1706. PubMed ID: 34245912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment.
    Joviano-Santos JV; Santos-Miranda A; Neri EA; Fonseca-Alaniz MH; Krieger JE; Pereira AC; Roman-Campos D
    Life Sci; 2021 Aug; 278():119646. PubMed ID: 34048814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of genotype-phenotype correlation in Brugada Syndrome and Sudden Arrhythmic Death Syndrome families with reported pathogenic SCN1B variants.
    Gray B; Hasdemir C; Ingles J; Aiba T; Makita N; Probst V; Wilde AAM; Newbury-Ecob R; Sheppard MN; Semsarian C; Sy RW; Behr ER
    Heart Rhythm; 2018 Jul; 15(7):1051-1057. PubMed ID: 29758173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
    Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.